NeuraModix is committed to the development, clinical evaluation and commercialization of a comprehensive state-of-the-art neuromodulation system for the treatment of chronic headache disorders, with initial focus on chronic migraine.
NeuraModix is a development stage medical device company that has built a veteran medical device team with a rich history of successful medical devices and world class medical advisory boards. All the key elements are assembled to initiate pre-clinical studies. We are looking for the right Series A investment partners to join the team and help bring relief to millions of chronic migraineurs.
